mhurhangee/ep-ind-claims huggingface dataset:
A method for manufacturing an alloy member, the member being made of an IN625 or an N263 nickel-based alloy to be used for a high-temperature member of a thermal power plant and comprising a coarse grain layer, characterized in that the method comprises the steps of: forming a stirred layer by giving processing strain to at least a part of the surface of the coarse grain layer using a friction stir processing, and then forming a recrystallized structure layer including finer grains than the coarse grain layer, by applying a heat treatment at a recrystallization temperature or more to the stirred layer for recrystallization, whereby: the recrystallized structure layer is composed of grains having an average size of 1 μm or more and 100 μm or less, and a thickness of the recrystallized structure layer is 1 mm or more and 5 mm or less. forming a stirred layer by giving processing strain to at least a part of the surface of the coarse grain layer using a friction stir processing, and then forming a recrystallized structure layer including finer grains than the coarse grain layer, by applying a heat treatment at a recrystallization temperature or more to the stirred layer for recrystallization, whereby: the recrystallized structure layer is composed of grains having an average size of 1 μm or more and 100 μm or less, and a thickness of the recrystallized structure layer is 1 mm or more and 5 mm or less. the recrystallized structure layer is composed of grains having an average size of 1 μm or more and 100 μm or less, and a thickness of the recrystallized structure layer is 1 mm or more and 5 mm or less.
An electric compressor, comprising: an electric motor having a stator and a rotor; a compressing mechanism having an eccentric shaft, rotatably and slidably connected to the rotor and defining a compressing chamber therein, the compressing chamber being configured to perform a compression by the eccentric shaft; and characterised by a torque damping device configured to connect the rotor with the eccentric shaft, wherein the torque damping device comprises one of a torsion bar spring, a helical torsion coil spring and a spiral spring which have actuation ends (B49,C45) connected to the eccentric shaft and the rotor respectively, and wherein during the compression of the compressing chamber, a difference between a rotation angle of the eccentric shaft and a rotation angle of the rotor is a phase angle which is increased and decreased, and wherein the torsion bar spring, the helical torsion coil spring or the spiral spring is configured as a non-linear spring having a spring constant which increases with an increase of the phase angle. an electric motor having a stator and a rotor; a compressing mechanism having an eccentric shaft, rotatably and slidably connected to the rotor and defining a compressing chamber therein, the compressing chamber being configured to perform a compression by the eccentric shaft; and characterised by a torque damping device configured to connect the rotor with the eccentric shaft, wherein the torque damping device comprises one of a torsion bar spring, a helical torsion coil spring and a spiral spring which have actuation ends (B49,C45) connected to the eccentric shaft and the rotor respectively, and wherein during the compression of the compressing chamber, a difference between a rotation angle of the eccentric shaft and a rotation angle of the rotor is a phase angle which is increased and decreased, and wherein the torsion bar spring, the helical torsion coil spring or the spiral spring is configured as a non-linear spring having a spring constant which increases with an increase of the phase angle.
A method of preparing a compound represented by the following formula: wherein R 1 is methyl; and R 2 is methyl, the method comprising: a) reacting maytansinol with an N -carboxyanhydride in a reaction mixture additionally comprising a base and a drying agent, wherein the N -carboxyanhydride is represented by the following formula: thereby forming the compound of Formula (Ia); and b) reacting unreacted N -carboxyanhydride from the reaction mixture in step a) with a nucleophilic reagent, wherein the nucleophilic reagent is water. a) reacting maytansinol with an N -carboxyanhydride in a reaction mixture additionally comprising a base and a drying agent, wherein the N -carboxyanhydride is represented by the following formula: thereby forming the compound of Formula (Ia); and b) reacting unreacted N -carboxyanhydride from the reaction mixture in step a) with a nucleophilic reagent, wherein the nucleophilic reagent is water.
A particle filter comprising a wall-flow filter and SCR-active material, wherein the wall-flow filter comprises channels which extend parallelly between a first and a second end of the wall-flow filter, which are alternatingly sealed in a gas-tight manner either at the first or at the second end, and which are separated by porous walls, and wherein the SCR active material comprises a zeolite which is exchanged with copper and/or with iron and is present in the form of a coating in the porous walls of the wall-flow filter, characterized in that the SCR-catalytically active material contains palladium. the wall-flow filter comprises channels which extend parallelly between a first and a second end of the wall-flow filter, which are alternatingly sealed in a gas-tight manner either at the first or at the second end, and which are separated by porous walls, and wherein the SCR active material comprises a zeolite which is exchanged with copper and/or with iron and is present in the form of a coating in the porous walls of the wall-flow filter, characterized in that the SCR-catalytically active material contains palladium.
A component that generates or requires heat, the component including: a component housing holding functional parts of the component that generate or require heat; a heat exchanger having a heat exchanger housing; and a first fluid circuit in which a first fluid flows through the component in a heat exchange relationship with the functional parts, into the heat exchanger housing via a first fluid inlet of the heat exchanger housing, through the heat exchanger, out of the heat exchanger housing via a first fluid outlet of the heat exchanger housing, and back to the functional parts of the component; wherein the heat exchanger housing has a second fluid inlet and a second fluid outlet for connection into a second fluid circuit in which a second fluid flows from outside of the component into the component housing and into the heat exchanger housing via the second fluid inlet, through the heat exchanger, out of the heat exchanger housing via the second fluid outlet and out of the component housing; and characterised in that the heat exchanger housing is formed integrally with the component housing, and the heat exchanger housing contains a removable heat exchanger core for exchange of heat between the first fluid in the first fluid circuit and the second fluid in the second fluid circuit, with the heat exchanger core being separate to the heat exchanger housing and removable from the heat exchanger housing during maintenance operations. a component housing holding functional parts of the component that generate or require heat; a heat exchanger having a heat exchanger housing; and a first fluid circuit in which a first fluid flows through the component in a heat exchange relationship with the functional parts, into the heat exchanger housing via a first fluid inlet of the heat exchanger housing, through the heat exchanger, out of the heat exchanger housing via a first fluid outlet of the heat exchanger housing, and back to the functional parts of the component; wherein the heat exchanger housing has a second fluid inlet and a second fluid outlet for connection into a second fluid circuit in which a second fluid flows from outside of the component into the component housing and into the heat exchanger housing via the second fluid inlet, through the heat exchanger, out of the heat exchanger housing via the second fluid outlet and out of the component housing; and characterised in that the heat exchanger housing is formed integrally with the component housing, and the heat exchanger housing contains a removable heat exchanger core for exchange of heat between the first fluid in the first fluid circuit and the second fluid in the second fluid circuit, with the heat exchanger core being separate to the heat exchanger housing and removable from the heat exchanger housing during maintenance operations.
Gelling formulation for use thereof in pain treatment, wherein the formulation is put into contact with the surface of the mucous membranes of the mouth, said formulation comprising ketamine or a pharmaceutically acceptable salt thereof, 15 to 20g/100mL of a poloxamer, one or more pharmaceutically acceptable mucoadhesive agents and water.
A kitchen appliance comprising: a plurality of switched power loads (118, 119), each load (118, 119) being powered from a common alternating current power source operating at 50Hz, wherein each load is independently switched using a respective switching signal (516, 517) for zero crossing switching to achieve a desired average power output, and wherein the plurality of loads (118, 119) are a plurality of heating elements; and a processor apparatus adapted to generate a plurality of switching signals (516, 517) for controlling the plurality of loads (118, 119), wherein the plurality of switching signals (516, 517) are generated based on a respective switching sequence (424, 429) retrieved from a lookup table, wherein each switching sequence is indicative of a respective selective activation of the plurality of loads (118, 119) over a sequence of half or full cycles, wherein a summed switching sequence formed by adding each switching signal repeats within 4 or less half cycles of the common alternating current power source, wherein a combined switching signal for controlling the plurality of loads (118, 119) has one of: no frequency components less than 24 Hz; or frequency components above 24 Hz which have more energy than any frequency components below 24 Hz. a plurality of switched power loads (118, 119), each load (118, 119) being powered from a common alternating current power source operating at 50Hz, wherein each load is independently switched using a respective switching signal (516, 517) for zero crossing switching to achieve a desired average power output, and wherein the plurality of loads (118, 119) are a plurality of heating elements; and a processor apparatus adapted to generate a plurality of switching signals (516, 517) for controlling the plurality of loads (118, 119), wherein the plurality of switching signals (516, 517) are generated based on a respective switching sequence (424, 429) retrieved from a lookup table, wherein each switching sequence is indicative of a respective selective activation of the plurality of loads (118, 119) over a sequence of half or full cycles, wherein a summed switching sequence formed by adding each switching signal repeats within 4 or less half cycles of the common alternating current power source, wherein a combined switching signal for controlling the plurality of loads (118, 119) has one of: no frequency components less than 24 Hz; or frequency components above 24 Hz which have more energy than any frequency components below 24 Hz. no frequency components less than 24 Hz; or frequency components above 24 Hz which have more energy than any frequency components below 24 Hz.
A simulator system for teaching patient care to a user, the system comprising: a model of at least a portion of a human body, wherein the model comprises first and second lungs, a first fluid passage in fluid communication with the lungs, and a breathing valve, wherein the breathing valve is adapted to control the flow of fluid through the first fluid passage; a pneumatic module in fluid communication with first fluid passage and adapted for delivering pressurized fluid to the first fluid passage; a processor in communication with the breathing valve; and a memory in communication with the processor for storing a plurality of instructions for execution by the processor, the instructions including instructions for manipulating the breathing valve to regulate the flow of pressurized fluid from the pneumatic module through the first fluid passage to the first and second lungs. a model of at least a portion of a human body, wherein the model comprises first and second lungs, a first fluid passage in fluid communication with the lungs, and a breathing valve, wherein the breathing valve is adapted to control the flow of fluid through the first fluid passage; a pneumatic module in fluid communication with first fluid passage and adapted for delivering pressurized fluid to the first fluid passage; a processor in communication with the breathing valve; and a memory in communication with the processor for storing a plurality of instructions for execution by the processor, the instructions including instructions for manipulating the breathing valve to regulate the flow of pressurized fluid from the pneumatic module through the first fluid passage to the first and second lungs.
A method for determining a cancer, comprising detecting the level of anti-deoxyhypusine synthase autoantibody in a blood specimen obtained from a human, and determining digestive system cancer on the basis of an increase in the level of anti-deoxyhypusine synthase autoantibody in said blood specimen compared to a standard anti-deoxyhypusine synthase autoantibody level of a digestive system cancer-free subject as an index in said human.
A patch, comprising: a substrate and a drug layer laminated on at least one surface of the substrate, wherein the drug layer comprises at least one drug selected from oxybutynin and pharmaceutically acceptable salts thereof; an adhesive base; and 0.05 to 15% by mass of cholesterol, relative to a total mass of the drug layer.
Mesenchymal stem cells for use in preventing or treating stress response-induced lymphocytopenia, wherein said lymphocytopenia is induced by apoptosis, wherein said stress response-induced lymphocytopenia is lymphocytopenia induced by increased glucocorticoids.
Cleaning product comprising an aqueous anti-misting enzyme composition comprising a) 1 x 10 -4 to 10 wt% of the total weight of the aqueous anti-misting enzyme composition of a polyethylene oxide polymer having a molecular weight from 1 x 10 6 to 3.0 x 10 6; and b) 1 x 10 -4 wt% to 10 wt% of the total weight of the aqueous anti-misting enzyme composition of one or more enzymes. a) 1 x 10 -4 to 10 wt% of the total weight of the aqueous anti-misting enzyme composition of a polyethylene oxide polymer having a molecular weight from 1 x 10 6 to 3.0 x 10 6; and b) 1 x 10 -4 wt% to 10 wt% of the total weight of the aqueous anti-misting enzyme composition of one or more enzymes.
Device for comminuting free-flowing feedstock - comprising a housing surrounding a comminuting chamber in which a rotor rotating about an axis of rotation is arranged, said rotor being equipped with rotor tools over its circumference, - comprising a screen holder having a screen which extends along a circumferential portion of the rotor and is intended to separate the sufficiently comminuted material, - comprising a material inlet for loading the rotor with feedstock, and - comprising a material discharge for taking off the sufficiently comminuted material, - the screen holder being pivotable from a closed first position about a first pivot axis into an open second position for opening the housing, the screen holder additionally being pivotable about a second pivot axis into an open third position, characterized in that the first pivot axis and the second pivot axis extend transversely to one another. - comprising a housing surrounding a comminuting chamber in which a rotor rotating about an axis of rotation is arranged, said rotor being equipped with rotor tools over its circumference, - comprising a screen holder having a screen which extends along a circumferential portion of the rotor and is intended to separate the sufficiently comminuted material, - comprising a material inlet for loading the rotor with feedstock, and - comprising a material discharge for taking off the sufficiently comminuted material, - the screen holder being pivotable from a closed first position about a first pivot axis into an open second position for opening the housing, the screen holder additionally being pivotable about a second pivot axis into an open third position, characterized in that the first pivot axis and the second pivot axis extend transversely to one another.
Cosmetic use of an effective amount of at least an ingredient containing chicoric acid or derivatives thereof, in combination with a lactic acid bacterium and/or an enzyme capable of hydrolyzing chicoric acid to generate tartaric or caffeic acid in an oral food supplement, said derivatives of chicoric acid having the formula: wherein R 1, R 2, R 3 and/or R 4 are identical or differ from one another and are selected from the group consisting of: H, CH 3, C 1 -C 3 -alkyl, aryl, C 1 -C 3 -acyl, amino acids, monosaccharides, disaccharides or oligosaccharides; for lightening and/or whitening skin tone. wherein R 1, R 2, R 3 and/or R 4 are identical or differ from one another and are selected from the group consisting of: H, CH 3, C 1 -C 3 -alkyl, aryl, C 1 -C 3 -acyl, amino acids, monosaccharides, disaccharides or oligosaccharides; for lightening and/or whitening skin tone.
Assembly consisting of a passageway, delimited by side delimitations (5a, 5b), for livestock, such as cattle, from a first space to a second space, wherein a gate system is mounted in the passageway, wherein the gate system has at least one self-closing gate leaf (6a; 6b) which is movable between a closed position and one or more open positions, including a pass position wherein for an animal from the livestock passage to the second space is possible, also provided with means for counting the number of animals which have passed through the passageway to the second space, wherein the counting means are configured for issuing a count signal as a function of a movement, observed by observation means, of the gate leaf.
Method for uplink control information transmission performed by a User Equipment, UE, in a radio communication system utilizing carrier aggregation, wherein a number of uplink component carriers can be aggregated for communication between the UE,and a network node in said system, characterized in: - selecting, if a set including at least Z two of said number of uplink component carriers includes at least one uplink component carrier comprising an uplink shared channel, one of said at least one uplink component carrier comprising an uplink shared channel for said transmission of said uplink control information in said uplink shared channel, wherein said selection is based on a priority indication information in which each of said at least one uplink component carrier of said set is assigned a priority indication; and - transmitting said uplink control information in the uplink shared channel of the selected one uplink component carrier; wherein said priority indication information is dynamically determined in accordance with a predetermined rule. - selecting, if a set including at least Z two of said number of uplink component carriers includes at least one uplink component carrier comprising an uplink shared channel, one of said at least one uplink component carrier comprising an uplink shared channel for said transmission of said uplink control information in said uplink shared channel, wherein said selection is based on a priority indication information in which each of said at least one uplink component carrier of said set is assigned a priority indication; and - transmitting said uplink control information in the uplink shared channel of the selected one uplink component carrier;
A method comprising, performed by at least one device: obtaining navigation data for at least one satellite navigation system from at least one terrestrial apparatus, wherein one of the at least one satellite navigation system is Galileo, the obtained navigation data corresponding to navigation data transmitted by a satellite of Galileo; assembling information comprising navigation data for Galileo and further data in an interrelated manner such that at least one message authentication code included in addition for the navigation data for Galileo is usable at a further device at the same time for verifying authenticity of the navigation data for Galileo and the further data, wherein the further data comprises navigation data for at least one further satellite navigation system; and causing transmission of the information to the further device. obtaining navigation data for at least one satellite navigation system from at least one terrestrial apparatus, wherein one of the at least one satellite navigation system is Galileo, the obtained navigation data corresponding to navigation data transmitted by a satellite of Galileo; assembling information comprising navigation data for Galileo and further data in an interrelated manner such that at least one message authentication code included in addition for the navigation data for Galileo is usable at a further device at the same time for verifying authenticity of the navigation data for Galileo and the further data, wherein the further data comprises navigation data for at least one further satellite navigation system; and causing transmission of the information to the further device.
A pharmaceutical composition for use in the treatment of a vascular insufficiency, wherein the vascular insufficiency is an ischemia comprising a restriction of blood flow due to arterial stenosis or occlusion, the pharmaceutical composition being sterile and comprising: (i) a therapeutically effective amount of a nonexpanded, isolated population of autologous mononuclear cells enriched for CD34+ cells which further contain a subpopulation of potent CD34+/CXCR-4+ cells that have chemotactic activity mediated by SDF-1 and/or CXCR-4, wherein the therapeutic amount is at least 10 x 10 6 isolated autologous CD34+ hematopoietic stem cells containing a subpopulation of at least 0.5 x 10 6 potent CD34+ cells expressing CXCR-4 and having CXCR-4 mediated chemotactic activity, and (ii) a stabilizing amount of serum at a concentration of at least 10% expressed as ml/100 cc final volume of the composition, which enables the subpopulation of potent CD34+/CXCR-4+ cells to retain their CXCR-4 mediated chemotactic activity and hematopoietic colony forming ability; wherein the composition is formulated for administration parenterally through a catheter, and wherein potency of the cells is maintained as they pass through the catheter. (i) a therapeutically effective amount of a nonexpanded, isolated population of autologous mononuclear cells enriched for CD34+ cells which further contain a subpopulation of potent CD34+/CXCR-4+ cells that have chemotactic activity mediated by SDF-1 and/or CXCR-4, wherein the therapeutic amount is at least 10 x 10 6 isolated autologous CD34+ hematopoietic stem cells containing a subpopulation of at least 0.5 x 10 6 potent CD34+ cells expressing CXCR-4 and having CXCR-4 mediated chemotactic activity, and (ii) a stabilizing amount of serum at a concentration of at least 10% expressed as ml/100 cc final volume of the composition, which enables the subpopulation of potent CD34+/CXCR-4+ cells to retain their CXCR-4 mediated chemotactic activity and hematopoietic colony forming ability;